This the 3 red lines pretending to be an E in Biden's logo?
The same three lines that are running in the Green New Deal BS ads on TV?
The fact that the Clinton's secret service names all started with and E?
kekish double meanings - REEEEEEEEEE
Lab Coats before Delta?
Delta was created in the Lab?
SHOT heard round the world?
Toxic Vax. Gain of Function?
Can we get the TRUTH???
Delta variant substantially more contagious than other variants, CDC presentation warns
Evidence is mounting about the dangers of the delta variant and how mask-wearing is essential to bring it under control, according to a government slideshow dated Thursday.
The presentation, compiled by a doctor with the Centers for Disease Control and Prevention, lays out what is known about the delta variant, which now accounts for the vast majority of COVID-19 cases in the United States.
Earlier this week, the CDC recommended that people in COVID-19 hotspots resume mask-wearing in indoor public spaces.
The agency had been criticized for making the recommendation without adequately supporting its reasons for the policy shift. But the presentation, first made public by The Washington Post, appears to do just that.
CDC declined to comment late Thursday on the slideshow or its contents.
The presentation shows that those who are vaccinated are three times less likely to catch COVID-19 and 10-times less likely to die from it than those who are unvaccinated.
Once infected, though, vaccinated people are just as contagious as those without that protection — meaning they need to wear a mask and keep their distance to avoid passing on the virus.
"The data makes a pretty compelling justification for why we need to go back to mask wearing and other public health measures," said Dr. Charles Chiu, an infectious disease specialist at the University of California, San Francisco. "I do think it's because of the delta variant."
more
https://www.yahoo.com/news/youre-vulnerable-cdc-presentation-warns-044715049.html
Potential Benefits of Gain-of-Function Research
Copyright 2015by the National Academy of Sciences. All rights reserved.
Bookshelf ID: NBK285583
Research using Gain-of-Function (GoF) techniques is no different with respect to what it can achieve in the long term, at least according to many of the symposium participants. Atlas noted that, although there was no attempt to achieve a consensus, no disagreement was voiced to the repeated claims of various presenters that in the short term GoF research is helpful for adapting viruses to growth in culture and for developing essential animal models for emerging pathogens, such as Middle East Respiratory Syndrome coronavirus (MERS-CoV), and escape mutations to understand drug resistance and viral evasion of the immune system. In the long-term it may also allow the generation of information that is not obtainable through other methods, but whether all the long-term benefits envisioned for GoF research will actually be realized is still unclear. Vaccine producers in particular disagree on whether GoF methods are essential for vaccine development, so the contributions of GoF research to vaccine development need careful evaluation. Increasing reliance on gene sequences to predict phenotypes may increase GoF research's importance over time. As was clear from the presentations in Session 4 of the symposium, there is wide recognition that it is not yet possible to predict phenotype from genotype, but Dr. Philip Dormitzer, from Novartis Vaccines and a member of the symposium planning committee, noted that as more genotype-phenotype linkages are established, it may enable keeping certain viral characteristics out of vaccine strains.
SURVEILLANCE, DETECTION, AND PREDICTION
The first presentation in Session 4 was given by Dr. Stacey Schultz-Cherry, St. Jude Children's Research Hospital, who discussed the information garnered from GoF studies about what she believes are its public health implications. Her home institution is one of five National Institute of Allergy and Infectious Diseases (NIAID) Centers of Excellence for Influenza Research and Surveillance in the United States and focuses on the animal-human interface. St. Jude is also a World Health Organization (WHO) collaborating center for studies on the ecology of influenza and is part of a global influenza surveillance and response system that includes six WHO collaborating centers and 144 national influenza centers throughout the world. St. Jude collaborates with colleagues in the animal health sector and their main role is to decide on the influenza strains that are incorporated into the seasonal flu vaccines. They also decide whether vaccines or candidate vaccine viruses are needed for emerging zoonotic threats.
The national influenza centers conduct viral strain surveillance throughout the year, looking at the genetic information from human as well as emerging zoonotic viruses. Every February and September, representatives from the WHO centers and central regulatory laboratories as well as animal health experts go through the surveillance data to decide on which viruses to choose as vaccine strains. This information is given to the vaccine manufacturers and regulatory agencies, and 6-9 months later the vaccines become available. She described many of the complexities of the process. She noted, in particular, that determining the function of amino acid changes in the viruses circulating in the field is one of the key tasks. As an example, she discussed an ongoing outbreak of H5 viruses in Cambodia. Through GoF research, it has been determined that the presence of certain genetic markers in the outbreak strain suggested that this particular virus could be more readily transmitted, at least in ferrets. This information has provided the persuasive factor to move forward with the development of a vaccine.
Schultz-Cherry noted that GoF research-derived information is also used for risk assessment. The U.S. Centers for Disease Control and Prevention has developed a risk assessment tool, the Influenza Risk Assessment Tool, to rank the risk associated with particular viruses. She stated that the result of using the Tool is not a prediction of the next pandemic, but rather an objective means of prioritizing viruses for future risk management. The Tool looks at the properties of a virus. What kind of receptors does it bind to? Is it more mammalian or avian? Does it transmit in animal models, or does it have molecular signatures that would suggest transmissibility? What is its genomic variation? She stated that all of this information, especially the molecular determinants of transmissibility, has been generated through GoF studies at some point, perhaps even as far back as the 1970s. She stated that the ability to prioritize is important because of limited resources; vaccines cannot be made for every new emerging virus.
Lots more
https://www.ncbi.nlm.nih.gov/books/NBK285583/
One World. Agenda 2030
A bold plan for Pope Francis, Bill Gates to save the world
Published: June 26, 2014 at 7:21 a.m. ET
Pope Francis has already warned us of the three self-destructive trends: First: unsustainable global warming and climate change on Planet-Earth. Second: The pope says the global economy is “near collapse” as inequality increases, fueling revolutions. Third: Earth’s natural resources will be unable to feed the 10 billion people living in 2050. The three go hand-in-hand, merge, with trigger mechanisms cross-linked to ignite simultaneously.
True, Pope Francis, Bill Gates and many other billionaires are already working on philanthropic projects of personal interest. Now it’s time to combine forces, see the world as one entity, search for common solutions. For as Ben Franklin put it during the signing of the Declaration of Independence back in 1776: “We must, indeed, all hang together, or assuredly we shall all hang separately.”
https://www.marketwatch.com/story/a-modest-plan-for-pope-francis-bill-gates-to-save-the-world-2014-06-25